134 related articles for article (PubMed ID: 14981182)
1. Neuronal cell injury precedes brain atrophy in multiple sclerosis.
Ge Y; Gonen O; Inglese M; Babb JS; Markowitz CE; Grossman RI
Neurology; 2004 Feb; 62(4):624-7. PubMed ID: 14981182
[TBL] [Abstract][Full Text] [Related]
2. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
[TBL] [Abstract][Full Text] [Related]
3. Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations.
Gonen O; Moriarty DM; Li BS; Babb JS; He J; Listerud J; Jacobs D; Markowitz CE; Grossman RI
Radiology; 2002 Oct; 225(1):261-8. PubMed ID: 12355014
[TBL] [Abstract][Full Text] [Related]
4. Total brain N-acetylaspartate: a new measure of disease load in MS.
Gonen O; Catalaa I; Babb JS; Ge Y; Mannon LJ; Kolson DL; Grossman RI
Neurology; 2000 Jan; 54(1):15-9. PubMed ID: 10636119
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of three whole-brain N-acetylaspartate decline cohorts in relapsing-remitting multiple sclerosis.
Gonen O; Oberndorfer TA; Inglese M; Babb JS; Herbert J; Grossman RI
AJNR Am J Neuroradiol; 2007 Feb; 28(2):267-71. PubMed ID: 17296992
[TBL] [Abstract][Full Text] [Related]
6. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis.
Rovaris M; Gallo A; Falini A; Benedetti B; Rossi P; Comola M; Scotti G; Comi G; Filippi M
Arch Neurol; 2005 Jun; 62(6):898-902. PubMed ID: 15956160
[TBL] [Abstract][Full Text] [Related]
7. Proton MR spectroscopy and MRI-volumetry in mild traumatic brain injury.
Cohen BA; Inglese M; Rusinek H; Babb JS; Grossman RI; Gonen O
AJNR Am J Neuroradiol; 2007 May; 28(5):907-13. PubMed ID: 17494667
[TBL] [Abstract][Full Text] [Related]
8. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
De Stefano N; Matthews PM; Fu L; Narayanan S; Stanley J; Francis GS; Antel JP; Arnold DL
Brain; 1998 Aug; 121 ( Pt 8)():1469-77. PubMed ID: 9712009
[TBL] [Abstract][Full Text] [Related]
9. Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.
Rigotti DJ; Gass A; Achtnichts L; Inglese M; Babb JS; Naegelin Y; Hirsch J; Amann M; Kappos L; Gonen O
Mult Scler; 2012 Jan; 18(1):98-107. PubMed ID: 21921070
[TBL] [Abstract][Full Text] [Related]
10. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.
Inglese M; Ge Y; Filippi M; Falini A; Grossman RI; Gonen O
Neuroimage; 2004 Apr; 21(4):1825-9. PubMed ID: 15050603
[TBL] [Abstract][Full Text] [Related]
11. Whole brain N-acetylaspartate concentration is conserved throughout normal aging.
Wu WE; Gass A; Glodzik L; Babb JS; Hirsch J; Sollberger M; Achtnichts L; Amann M; Monsch AU; Gonen O
Neurobiol Aging; 2012 Oct; 33(10):2440-7. PubMed ID: 22245316
[TBL] [Abstract][Full Text] [Related]
12. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.
Filippi M; Bozzali M; Rovaris M; Gonen O; Kesavadas C; Ghezzi A; Martinelli V; Grossman RI; Scotti G; Comi G; Falini A
Brain; 2003 Feb; 126(Pt 2):433-7. PubMed ID: 12538409
[TBL] [Abstract][Full Text] [Related]
13. Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
Achtnichts L; Gonen O; Rigotti DJ; Babb JS; Naegelin Y; Penner IK; Bendfeldt K; Hirsch J; Amann M; Kappos L; Gass A
Eur J Radiol; 2013 Dec; 82(12):e848-52. PubMed ID: 24041438
[TBL] [Abstract][Full Text] [Related]
14. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
15. Whole-brain N-acetylaspartate level and cognitive performance in HIV infection.
Patel SH; Inglese M; Glosser G; Kolson DL; Grossman RI; Gonen O
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1587-91. PubMed ID: 13679275
[TBL] [Abstract][Full Text] [Related]
16. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
[TBL] [Abstract][Full Text] [Related]
17. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
[TBL] [Abstract][Full Text] [Related]
18. Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
Rigotti DJ; Inglese M; Kirov II; Gorynski E; Perry NN; Babb JS; Herbert J; Grossman RI; Gonen O
Neurology; 2012 May; 78(18):1383-9. PubMed ID: 22517095
[TBL] [Abstract][Full Text] [Related]
19. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Chiarini P; Gallai V
J Neurol; 2002 Jul; 249(7):902-10. PubMed ID: 12140676
[TBL] [Abstract][Full Text] [Related]
20. Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis.
Rocca MA; Mezzapesa DM; Falini A; Ghezzi A; Martinelli V; Scotti G; Comi G; Filippi M
Neuroimage; 2003 Apr; 18(4):847-55. PubMed ID: 12725761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
